Your body makes thousands of peptides — and only about 300 have a proven job.
The big numbers you see quoted are real, and they come from the peptidomics literature rather than from marketing copy. But it counts peptides that have been identified, not peptides that have been shown to do something. The distance between those two numbers is the most interesting thing about the whole subject.
- Thousands of distinct natural peptides have been identified in the human body, and a widely repeated estimate puts a comparable number present at any one time.
- Only about 300 human peptides have confirmed bioactivity, even though tens of thousands have been reported in the literature.
- Most of the remainder are degradation fragments of larger proteins — real molecules, but with no demonstrated signalling role.
- The body multiplies a modest number of precursor genes into thousands of peptides by cutting the precursors up and then chemically modifying the pieces.
- A large peptidome is not a large menu of usable compounds. The well-characterised set is small, and it is the only set with pharmacokinetic data worth trusting.
Where the big numbers come from
Elsevier’s reference overview of peptide hormones states plainly that many thousands of natural peptides have so far been identified in the human body, showing a wide range of biological activities. A frequently quoted science-communication version puts a comparable number present in the body at any given moment, not all of them identified — a framing that comes from McGill University’s Office for Science and Society.
Both framings are defensible, and they are not quite the same claim. One counts entries on a list built up over decades of research. The other estimates how many distinct peptide species are floating around in you right now. Neither says anything about what those peptides do.
Identified is not the same as active
This is where the headline number stops being impressive and starts being informative. A 2025 review in Trends in Biochemical Sciences notes that only about 300 peptides in humans have confirmed bioactivity, despite tens of thousands being reported in the literature — a volume that simply exceeds the capacity for functional testing.
The same figure appears independently in the peptidomics methods literature, which describes the problem in blunter terms: the majority of detected peptides are inactive degradation products of endogenous proteins, and finding the promising candidates among them is a needle-in-a-haystack exercise. That is why machine-learning approaches are now being trained on mass-spectrometry data to predict which peptides are worth testing at all.
So the honest version of the headline is: your body contains thousands of distinct peptide species, the overwhelming majority of which are protein breakdown products that nobody has shown to signal anything.
How a few precursors become thousands of peptides
Peptides are not usually transcribed as finished products. The body makes a larger precursor protein — a prohormone — and then cuts it. Proteolytic cleavage of those precursors is the first mechanism that multiplies the repertoire: one precursor can yield several different fragments, each with its own fate.
The second mechanism is chemical modification after cleavage. Amidation, sulfation, pyroglutamylation, phosphorylation and glycosylation each change the molecule’s behaviour, and the same peptide sequence carrying different modifications can behave differently in the body. These post-translational modifications are what allow a limited set of genes to produce a genuinely diverse peptidome, and the review literature is explicit that additional enzymes and modifications in this process remain unidentified.
What peptides actually do
The dominant role of peptides in biological systems is signalling. They typically bind receptors on the outside of the cell — frequently G-protein-coupled receptors — and trigger a cascade inside it. Because peptides are water-soluble, they cannot cross the cell membrane the way steroid hormones do. That single physical fact explains a lot: peptide signals tend to act fast and fade fast, while steroids act more slowly and persist.
Within the peptides that do have established roles, the usual groupings are peptide hormones, neuropeptides, antimicrobial peptides, and growth factors. Estimates of how many distinct human peptide hormones exist range from roughly 100 to a few hundred, depending on whether you count splice variants and modified forms separately — which is a reminder that even the small, well-studied number is a matter of definition.
Why this matters if you buy research peptides
Big peptide counts travel well in marketing because they imply abundance: a vast catalogue of biological tools waiting to be used. The literature does not support that reading. The number of peptides with a demonstrated function is small, and the number with published human pharmacokinetics — a measured half-life, a known clearance route — is smaller still.
That subset is the one worth paying attention to. It is also the reason a peptide can be entirely real, entirely present in human tissue, and still have no meaningful dosing literature behind it. Existence is not evidence of function, and function is not evidence of a usable protocol.
We only model a pharmacokinetic curve where published half-life data exists. Where a compound has no established terminal half-life, the entry says so instead of drawing a curve from data that does not exist. The gap described in this article is exactly why that policy exists.
Sources
- Understanding peptide hormones: from precursor proteins to bioactive molecules. Trends in Biochemical Sciences, 2025. www.cell.com
- Combining mass spectrometry and machine learning to discover bioactive peptides. Nature Communications, 2022 (PMC9584923). www.ncbi.nlm.nih.gov
- Peptide Hormone — overview. ScienceDirect Topics, Elsevier. www.sciencedirect.com
- There is Much Pep in Peptide Research. McGill Office for Science and Society, 2025. www.mcgill.ca